MBII
Marrone Bio Innovations, Inc.
MBII
MBII
Delisted
MBII was delisted on the 12th of July, 2022.
53 hedge funds and large institutions have $40.5M invested in Marrone Bio Innovations, Inc. in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
10
Increased
13
Reduced
17
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$644K |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$188K |
3 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$101K |
4 |
Geode Capital Management
Boston,
Massachusetts
|
+$43.5K |
5 |
Northern Trust
Chicago,
Illinois
|
+$35.4K |
Top Sellers
1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$104K |
2 |
Primecap Management
Pasadena,
California
|
-$57.2K |
3 |
Morgan Stanley
New York
|
-$53.3K |
4 |
Goldman Sachs
New York
|
-$41.1K |
5 |
BlackRock
New York
|
-$38.9K |